$Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis$

Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis

Less frequent bisphosphonate dosing in women with postmenopausal osteoporosis has the potential to promote therapy adherence through improved convenience. Ibandronate is a highly potent nitrogen-containing bisphosphonate, proven to significantly increase vertebral and nonvertebral bone mineral densi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone (New York, N.Y.) N.Y.), 2004-05, Vol.34 (5), p.890-899
Hauptverfasser:	Recker, R, Stakkestad, J.A, Chesnut, C.H, Christiansen, C, Skag, A, Hoiseth, A, Ettinger, M, Mahoney, P, Schimmer, R.C, Delmas, P.D
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Bisphosphonate Bone Resorption - drug therapy Diphosphonates - administration & dosage Diphosphonates - therapeutic use Diseases of the osteoarticular system Double-Blind Method Female Fractures, Bone - prevention & control Fundamental and applied biological sciences. Psychology Humans Ibandronate Infusions, Intravenous Injection Intravenous Medical sciences Middle Aged Osteoporosis Osteoporosis - drug therapy Osteoporosis. Osteomalacia. Paget disease Placebos Postmenopause Traumas. Diseases due to physical agents Vertebrates: anatomy and physiology, studies on body, several organs or systems
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!